StudyFinder
Search Results Within Category "Cancer"
Suggestions within category "Cancer"
Bladder Cancer
Blood Cancers
Brain Cancer
Breast Cancer
Cancer Survivors
Childhood Cancer
Colon Cancer
Genetic Cancer Syndromes
Head and Neck Cancer
Kidney Cancer
Liver Cancer
Lung Cancer
Phase I Clinic
Prostate Cancer
Soft Tissue and Bone Cancer
Stomach Cancer
1 Study Matches
A phase III, single-arm study to evaluate the efficacy and safety of ONCOFID-P-B (paclitaxel-hyaluronic acid conjugate) administered intravesically to patients with BCG- unresponsive Carcinoma in Situ of the bladder with or without Ta-T1 papillary disease
The purpose of this study is to understand if the study medication ONCOFID-P-B is effective and safe in treating patients with carcinoma in situ of the bladder who have not received benefit from standard BCG treatment and are not candidates for radical cystectomy.
Hamed Ahmadi
18 years and over
STUDY00019273
Inclusion Criteria:
• persistent or recurrent confirmed carcinoma in situ (CIS) of the bladder
• unresponsive to BCG treatment and refuse radical cystectomy or are not clinically suitable for cystectomy
• able to walk and capable of all selfcare but unable to carry out any work activities; up and about more than 50% of waking hours
• women and men of child bearing age must follow specific requirements for birth control
Exclusion Criteria:
• current or previous muscle-invasive cancer or metastatic urothelial cancer
• current or prior systemic therapy for bladder cancer.
• women who are pregnant or breast feeding
• additional medical or mental health diagnosis (study staff will review)
Cancer
Clinics and Surgery Center (CSC), Bladder Cancer in Situ (CIS), Bladder CIS